Search results

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.